Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
MeMed Diagnostics Ltd.
With
Rambam Health Care Campus
Carmel Medical Center
Rabin Medical Center
European Commission
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patients aged 18 years and older who agree (or their legal guardian agree) to sign an informed consent will be eligible for inclusion.
The LRTI cohorts should also fulfill the following criteria:
* Peak measured (not tactile, self-reported acceptable) temperature ≥ 37.8°C (100°F) within the last 7 days (AND)
* Symptoms duration ≤7 days (AND)
* Clinical suspicion of LRTI or pneumonia
You may not be if
Oral/intravenous/intramuscular antibiotic treatment of over 48/12/12 hours' duration at time of enrollment (respectively), unless temperature ≥ 37.8°C was measured within the last 2 days
Another episode of an acute infection during the last 2 weeks
Congenital immune deficiency (CID)
A proven or suspected human immunodeficiency virus (HIV)-1, hepatitis B virus (HBV), or hepatitis C virus (HCV) infection
Active malignancy
Pregnancy
Current treatment with immune-suppressive or immune-modulating therapies including without limitations:
* Use of high dose steroids \>1 mg/kg/day prednisone or equivalent in the past two weeks
* Moderate to severe congenital metabolic disorder
Clareo Health | Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
